NeoGenomics, Inc. recently showcased new assay data and highlighted its RaDaR ST molecular residual disease test at the European Society for Medical Oncology Congress 2025, presenting how this ...
Kelly Ventures Ltd. (TSXV: KKL.P) ("Kelly Ventures" or the "Issuer"), a capital pool company, and Belag S.A. to be incorporated in the British Virgin Islands and which will own all of the issued and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback